Clinical trial
Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With…
NCT00269815 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00269815 |
|---|---|
| Title | Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder |
| Official title | Long-term Safety and Effectiveness of OROS (Methylphenidate HCl) in Children With ADHD |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | methylphenidate HCl |
| Completion | Dec 1, 1999 |
| First posted | Dec 26, 2005 |
| Last update posted | Jun 14, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: